Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Prostate Cancer

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 65 articles: HTML format Text format

Single Articles

May 2012
1. RUSSELL LH JR , Mazzio E, Badisa RB, Zhu ZP, et al
   Autoxidation of Gallic Acid Induces ROS-dependent Death in Human Prostate Cancer LNCaP Cells.
   Anticancer Res. 2012;32:1595-602.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. IACOPINO F , Angelucci C, Sica G
   Interactions Between Normal Human Fibroblasts and Human Prostate Cancer Cells in a Co-culture System.
   Anticancer Res. 2012;32:1579-88.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. MENEN R , Pinney E, Hassanein MK, Kolostova K, et al
   Inhibition of metastasis of circulating human prostate cancer cells in the chick embryo by an extracellular matrix produced by foreskin fibroblasts in culture.
   Anticancer Res. 2012;32:1573-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2012
4. PORCARO AB , Ghimenton C, Petrozziello A, Migliorini F, et al
   Investigative Clinical Study on Prostate Cancer Part VIII: Prolactin Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis and Subsequent Cluster Selection of the Patient Population after Radical Prostatectomy.
   Anticancer Res. 2012;32:1499-506.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
5. ARSOV C , Quentin M, Rabenalt R, Antoch G, et al
   Repeat Transrectal Ultrasound Biopsies with Additional Targeted Cores According to Results of Functional Prostate MRI Detects High-risk Prostate Cancer in Patients with Previous Negative Biopsy and Increased PSA - A Pilot Study.
   Anticancer Res. 2012;32:1087-92.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. PONHOLZER A , Lamche M, Klitsch M, Kraischits N, et al
   Sentinel lymphadenectomy compared to extended lymphadenectomy in men with prostate cancer undergoing prostatectomy.
   Anticancer Res. 2012;32:1033-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. HERVONEN P , Joensuu H, Joensuu T, Claes G, et al
   Biweekly Docetaxel Is Better Tolerated than Conventional Three-weekly Dosing for Advanced Hormone-refractory Prostate Cancer.
   Anticancer Res. 2012;32:953-956.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. SATOMI Y
   Fucoxanthin Induces GADD45A Expression and G1 Arrest with SAPK/JNK Activation in LNCap Human Prostate Cancer Cells.
   Anticancer Res. 2012;32:807-13.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. RAY R , Banks M, Abuzahra H, Eddy VJ, et al
   Effect of dietary vitamin D and calcium on the growth of androgen-insensitive human prostate tumor in a murine model.
   Anticancer Res. 2012;32:727-31.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
10. 
    After prostate cancer.
    Anticancer Res. 2012;32:718.
    PubMed     Text format     Related articles   
    
    
    
    
11. 
    Prostate cancer.
    Anticancer Res. 2012;32:718.
    PubMed     Text format     Related articles   
    
    
    
    
12. SCHALLIER D , Decoster L, Braeckman J, Fontaine C, et al
    Docetaxel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC): an Observational Study in a Single Institution.
    Anticancer Res. 2012;32:633-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
13. CHEN TC , Sakaki T, Yamamoto K, Kittaka A, et al
    The roles of cytochrome p450 enzymes in prostate cancer development and treatment.
    Anticancer Res. 2012;32:291-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. SAMUEL T , Fadlalla K, Mosley L, Katkoori V, et al
    Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells.
    Anticancer Res. 2012;32:61-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
15. PEPE P , Aragona F
    PCA3 Score vs PSA Free/Total Accuracy in Prostate Cancer Diagnosis at Repeat Saturation Biopsy.
    Anticancer Res. 2011;31:4445-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. DAUBINE F , LE Bot R, Marquez M, Nilsson S, et al
    Treatment of bone metastasis in prostate cancer: efficacy of a novel polybisphosphonate.
    Anticancer Res. 2011;31:4141-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. STIO M , Martinesi M, Simoni A, Zuegel U, et al
    The Novel Vitamin D Analog ZK191784 Inhibits Prostate Cancer Cell Invasion.
    Anticancer Res. 2011;31:4091-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. KIM HN , Narayanan NK, Lasano S, Narayanan B, et al
    Modulation of PGE2-induced EP4 expression on snail signaling and the impact on epithelial-mesenchymal transition: significance of EP4 antagonism.
    Anticancer Res. 2011;31:4347-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
19. PORCARO AB , Ghimenton C, Petrozziello A, Migliorini F, et al
    Investigative Clinical Study on Prostate Cancer Part VII: Prolactin and the Pituitary-Testis-Prostate Axis at the Time of Initial Diagnosis and Subsequent Cluster Selection of the Patient Population.
    Anticancer Res. 2011;31:3913-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. WAGNER W , Bolling T, Hambruegge C, Hartlapp J, et al
    Patients' Satisfaction with Different Modalities of Prostate Cancer Therapy - A Retrospective Survey among 634 Patients.
    Anticancer Res. 2011;31:3903-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. DORFF TB , Liu SV, Xiong S, Cai J, et al
    Ethnic differences in neuroendocrine expression in prostate cancer tissue.
    Anticancer Res. 2011;31:3897-901.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. RUSSELL LH JR , Mazzio E, Badisa RB, Zhu ZP, et al
    Differential Cytotoxicity of Triphala and its Phenolic Constituent Gallic acid on Human Prostate Cancer LNCap and Normal Cells.
    Anticancer Res. 2011;31:3739-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ADLER S , Rashid G, Klein A
    Indole-3-carbinol Inhibits Telomerase Activity and Gene Expression in Prostate Cancer Cell Lines.
    Anticancer Res. 2011;31:3733-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. SREEVALSAN S , Joseph S, Jutooru I, Chadalapaka G, et al
    Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.
    Anticancer Res. 2011;31:3799-807.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
25. VALERIANI M , Monaco F, Osti MF, DE Sanctis V, et al
    Hypofractionated Radiotherapy with or without IGRT in Prostate Cancer: Preliminary Report of Acute Toxicity.
    Anticancer Res. 2011;31:3555-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. KAI L , Levenson AS
    Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells.
    Anticancer Res. 2011;31:3323-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. WEISS TW , Simak R, Kaun C, Rega G, et al
    Oncostatin M and IL-6 Induce u-PA and VEGF in Prostate Cancer Cells and Correlate In Vivo.
    Anticancer Res. 2011;31:3273-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. ZHOU H , Zhang Y, Hamburger AW
    EBP1 Inhibits Translation of Androgen Receptor mRNA in Castration Resistant Prostate Cancer Cells.
    Anticancer Res. 2011;31:3129-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. PAZDIORA P , Svobodova S, Fuchsova R, Kucera R, et al
    Vitamin d in colorectal, breast, prostate and lung cancer: a pilot study.
    Anticancer Res. 2011;31:3619-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. KRATZIK C , Womastek I, Bieglmayer C, Schatzl G, et al
    Lower Serum Total Testosterone is Associated with Lymph Node Metastases in a Radical Prostatectomy Cohort Study.
    Anticancer Res. 2011;31:3615-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. MENEN RS , Pinney E, Kolostova K, Bobek V, et al
    A rapid imageable in vivo metastasis assay for circulating tumor cells.
    Anticancer Res. 2011;31:3125-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
32. SARKAR S , Abujamra AL, Loew JE, Forman LW, et al
    Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling.
    Anticancer Res. 2011;31:2723-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
33. HOLZER TR , Fulford AD, Arkins AM, Grondin JM, et al
    Ischemic time impacts biological integrity of phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK signaling networks.
    Anticancer Res. 2011;31:2073-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
34. KOUKOURAKIS MI , Kyrgias G, Papadopoulou A, Panteliadou M, et al
    Treatment of Low-risk Prostate Cancer with Radical Hypofractionated Accelerated Radiotherapy with Cytoprotection (HypoARC): An Interim Analysis of Toxicity and Efficacy.
    Anticancer Res. 2011;31:1745-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. NIEDER C , Norum J, Geinitz H
    Impact of Common Medications on Serum Total Prostate-specific Antigen Levels and Risk Group Assignment in Patients with Prostate Cancer.
    Anticancer Res. 2011;31:1735-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. TANG NY , Huang YT, Yu CS, Ko YC, et al
    Phenethyl Isothiocyanate (PEITC) Promotes G2/M Phase Arrest via p53 Expression and Induces Apoptosis through Caspase- and Mitochondria-dependent Signaling Pathways in Human Prostate Cancer DU 145 Cells.
    Anticancer Res. 2011;31:1691-702.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. KOLOSTOVA K , Pinterova D, Hoffman RM, Bobek V, et al
    Circulating Human Prostate Cancer Cells from an Orthotopic Mouse Model Rapidly Captured by Immunomagnetic Beads and Imaged by GFP Expression.
    Anticancer Res. 2011;31:1535-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. LI J , Ye L, Mansel RE, Jiang WG, et al
    Potential prognostic value of repulsive guidance molecules in breast cancer.
    Anticancer Res. 2011;31:1703-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
39. BOURNAKIS E , Efstathiou E, Varkaris A, Wen S, et al
    Time to Castration Resistance Is an Independent Predictor of Castration-resistant Prostate Cancer Survival.
    Anticancer Res. 2011;31:1475-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. STRAZDINA A , Krumina G, Sperga M
    The Value and Limitations of Contrast-enhanced Ultrasound in Detection of Prostate Cancer.
    Anticancer Res. 2011;31:1421-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. PANEBIANCO V , Sciarra A, DE Berardinis E, Busetto GM, et al
    PCA3 Urinary Test Versus 1H-MRSI and DCEMR in the Detection of Prostate Cancer Foci in Patients with Biochemical Alterations.
    Anticancer Res. 2011;31:1399-405.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
42. PORCARO AB , Petrozziello A, Migliorini F, Caruso B, et al
    Investigative clinical study on prostate cancer part v: luteinizing hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
    Anticancer Res. 2011;31:1071-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. BARNETT CM , Flamiatos JF, Beer TM
    Prolonged response to early docetaxel in a patient with biochemical relapse after primary therapy for prostate cancer and incomplete response to androgen suppression therapy.
    Anticancer Res. 2011;31:973-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
44. WU HC , Chang CH, Tsou YA, Tsai CW, et al
    Significant Association of Caveolin-1 (CAV1) Genotypes with Prostate Cancer Susceptibility in Taiwan.
    Anticancer Res. 2011;31:745-749.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. GORDANPOUR A , Stanimirovic A, Nam RK, Moreno CS, et al
    miR-221 Is Down-regulated in TMPRSS2:ERG Fusion-positive Prostate Cancer.
    Anticancer Res. 2011;31:403-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. ANDERSON KM , Guinan P, Rubenstein M
    The effect of normoxia and hypoxia on a prostate (PC-3) CD44/CD41 cell side fraction.
    Anticancer Res. 2011;31:487-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. SKELTON WP 4TH , Pi GE, Vesely DL
    Four cardiac hormones cause death of human cancer cells but not of healthy cells.
    Anticancer Res. 2011;31:395-402.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
48. WU HC , Chang CH, Ke HL, Chang WS, et al
    Association of Cyclooxygenase 2 Polymorphic Genotypes with Prostate Cancer in Taiwan.
    Anticancer Res. 2011;31:221-225.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. FADLALLA K , Watson A, Yehualaeshet T, Turner T, et al
    Ruta graveolens extract induces DNA damage pathways and blocks Akt activation to inhibit cancer cell proliferation and survival.
    Anticancer Res. 2011;31:233-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. LU L , Kanwar J, Schmitt S, Cui QC, et al
    Inhibition of tumor cellular proteasome activity by triptolide extracted from the Chinese medicinal plant 'thunder god vine'.
    Anticancer Res. 2011;31:1-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
51. IZUMI K , Kadono Y, Shima T, Konaka H, et al
    Ethinylestradiol Improves Prostate-specific Antigen Levels in Pretreated Castration-resistant Prostate Cancer Patients.
    Anticancer Res. 2010;30:5201-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. SHIMAZAKI J , Tsuji H, Ishikawa H, Okada T, et al
    Carbon ion radiotherapy for treatment of prostate cancer and subsequent outcomes after biochemical failure.
    Anticancer Res. 2010;30:5105-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. CHECK JH , Dix E, Wilson C, Check D, et al
    Progesterone receptor antagonist therapy has therapeutic potential even in cancer restricted to males as evidenced from murine testicular and prostate cancer studies.
    Anticancer Res. 2010;30:4921-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
54. KIM SY , Ryu JS, Li H, Park WJ, et al
    UVB-Activated Indole-3-Acetic Acid Induces Apoptosis of PC-3 Prostate Cancer Cells.
    Anticancer Res. 2010;30:4607-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
55. LADOIRE S , Eymard JC, Zanetta S, Mignot G, et al
    Metronomic Oral Cyclophosphamide Prednisolone Chemotherapy Is an Effective Treatment for Metastatic Hormone-refractory Prostate Cancer after Docetaxel Failure.
    Anticancer Res. 2010;30:4317-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. WU Y , Chhipa RR, Cheng J, Zhang H, et al
    Androgen Receptor-mTOR Crosstalk is Regulated by Testosterone Availability: Implication for Prostate Cancer Cell Survival.
    Anticancer Res. 2010;30:3895-901.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. ALCOVER J , Filella X, Luque P, Molina R, et al
    Prognostic value of IL-6 in localized prostatic cancer.
    Anticancer Res. 2010;30:4369-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. LIU IH , Chang CH, Ho CL, Chiu SP, et al
    Multimodality Imaging and Preclinical Evaluation of 177Lu-AMBA for Human Prostate Tumours in a Murine Model.
    Anticancer Res. 2010;30:4039-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
59. AZUMA H , Inamoto T, Takahara K, Ibuki N, et al
    Combination therapy with VP16 and ethinylestradiol for hormone-refractory prostate cancer: good response with tolerability.
    Anticancer Res. 2010;30:3737-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. MAZZUCCHELLI R , Nesseris I, Cheng L, Lopez-Beltran A, et al
    Active surveillance for low-risk prostate cancer.
    Anticancer Res. 2010;30:3683-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. PESTA M , Klecka J, Kulda V, Topolcan O, et al
    Importance of miR-20a expression in prostate cancer tissue.
    Anticancer Res. 2010;30:3579-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. WU HC , Chang CH, Tsai RY, Lin CH, et al
    Significant association of methylenetetrahydrofolate reductase single nucleotide polymorphisms with prostate cancer susceptibility in taiwan.
    Anticancer Res. 2010;30:3573-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. MO L , Zhang J, Shi J, Xuan Q, et al
    Human kallikrein 7 induces epithelial-mesenchymal transition-like changes in prostate carcinoma cells: a role in prostate cancer invasion and progression.
    Anticancer Res. 2010;30:3413-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. BUHLER P , Wetterauer D, Gierschner D, Wetterauer U, et al
    Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer.
    Anticancer Res. 2010;30:3373-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. DEEB D , Gao X, Jiang H, Arbab AS, et al
    Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells.
    Anticancer Res. 2010;30:3333-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: